Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

New Market Report: Sequella, Inc. - Product Pipeline Review - 2013


Print article Print article
2014-01-27 12:13:13 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Sequella, Inc. - Product Pipeline Review - 2013" provides data on the Sequella, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Sequella, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Sequella, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Sequella, Inc. - Brief Sequella, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Sequella, Inc. human therapeutic division.
* Overview of

pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Sequella, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Sequella, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/769485_sequella_inc_product_pipeline_review_ ..

Reasons to Get this Report

* Evaluate Sequella, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Sequella, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Sequella, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Sequella, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Sequella, Inc. and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Sequella, Inc. Snapshot
Sequella, Inc. Overview
Key Information
Key Facts
Sequella, Inc. - Research and Development Overview
Key Therapeutic Areas
Sequella, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Sequella, Inc. - Pipeline Products Glance
Sequella, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Sequella, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Sequella, Inc. - Drug Profiles
SQ-109
Product Description
Mechanism of Action
R&D Progress
sutezolid
Product Description
Mechanism of Action
R&D Progress
SQ-609
Product Description
Mechanism of Action
R&D Progress
SQ-641
Product Description
Mechanism of Action
R&D Progress
Sequella, Inc. - Pipeline Analysis
Sequella, Inc. - Pipeline Products by Therapeutic Class
Sequella, Inc. - Pipeline Products by Target
Sequella, Inc. - Pipeline Products by Route of Administration
Sequella, Inc. - Pipeline Products by Molecule Type
Sequella, Inc. - Pipeline Products by Mechanism of Action
Sequella, Inc. - Recent Pipeline Updates
Sequella, Inc. - Dormant Projects
Sequella, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
HspDNA Vaccine
Sequella, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Sequella, Inc., Key Information
Sequella, Inc., Key Facts
Sequella, Inc. - Pipeline by Indication, 2013
Sequella, Inc. - Pipeline by Stage of Development, 2013
Sequella, Inc. - Monotherapy Products in Pipeline, 2013
Sequella, Inc. - Partnered Products in Pipeline, 2013
Sequella, Inc. - Partnered Products/ Combination Treatment Modalities, 2013
Sequella, Inc. - Phase II, 2013
Sequella, Inc. - Preclinical, 2013
Sequella, Inc. - Discovery, 2013
Sequella, Inc. - Pipeline by Therapeutic Class, 2013
Sequella, Inc. - Pipeline by Target, 2013
Sequella, Inc. - Pipeline by Route of Administration, 2013
Sequella, Inc. - Pipeline by Molecule Type, 2013
Sequella, Inc. - Pipeline Products by Mechanism of Action, 2013
Sequella, Inc. - Recent Pipeline Updates, 2013
Sequella, Inc. - Dormant Developmental Projects,2013
Sequella, Inc. - Discontinued Pipeline Products, 2013

List of Figures
Sequella, Inc. - Pipeline by Top 10 Indication, 2013
Sequella, Inc. - Pipeline by Stage of Development, 2013
Sequella, Inc. - Monotherapy Products in Pipeline, 2013
Sequella, Inc. - Partnered Products in Pipeline, 2013
Sequella, Inc. - Pipeline by Top 10 Therapeutic Class, 2013
Sequella, Inc. - Pipeline by Top 10 Target, 2013
Sequella, Inc. - Pipeline by Top 10 Route of Administration, 2013
Sequella, Inc. - Pipeline by Top 10 Molecule Type, 2013
Sequella, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2013

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com